Evidence map›Paper›PMID 27652978›Full record

ArticleScientific reports2016

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease.

Natasa Kustrimovic, Emanuela Rasini, Massimiliano Legnaro, Raffaella Bombelli, Iva Aleksic, Fabio Blandini, Cristoforo Comi, Marco Mauri, Brigida Minafra, Giulio Riboldazzi and 3 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05173701 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Effects of Probiotics on Peripheral Immunity in Parkinson's Disease

TypeinterventionalSponsorFranca MarinoRan2021 to 2023Enrolled88ConditionsParkinson's DiseaseArmsProbiotics, Placebo
NCT06705517 narecruitingnot on this mapstarted 2025, after this paper: background citation

Mediterranean Diet Effects on Parkinson's Disease (MED-PARK): a Randomized Controlled Trial

TypeinterventionalSponsorUniversità degli Studi dell'InsubriaRan2025 to 2026Enrolled44ConditionsParkinson, Parkinson Disease, Parkinson Disease, Idiopathic, PARKINSON DISEASE (Disorder)ArmsMediterranean Diet
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2017
    Pooled it
  2. Review
  3. Shared Epitope-PositiveNeurology(R) neuroimmunology & neuroinflammation · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. International journal of molecular sciences · 2023
    Article
  17. Article
  18. Brain and Systemic Inflammation in De Novo Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2023
    Article
  19. Relationship between [Journal of neurology · 2023
    Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Natasa KustrimovicCenter of Research in Medical Pharmacology, University of Insubria, Varese, Italy.
Emanuela RasiniCenter of Research in Medical Pharmacology, University of Insubria, Varese, Italy.
Massimiliano LegnaroCenter of Research in Medical Pharmacology, University of Insubria, Varese, Italy.
Raffaella BombelliCenter of Research in Medical Pharmacology, University of Insubria, Varese, Italy.
Iva AleksicCenter of Research in Medical Pharmacology, University of Insubria, Varese, Italy.
Fabio BlandiniCenter for Research in Neurodegenerative Diseases, "C. Mondino", National Neurological Institute, Pavia, Italy.
Cristoforo ComiMovement Disorders Centre, Neurology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Marco MauriDepartment of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
Brigida MinafraCenter for Research in Neurodegenerative Diseases, "C. Mondino", National Neurological Institute, Pavia, Italy.
Giulio RiboldazziDepartment of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
Vanesa Sanchez-GuajardoNeuroimmunology of Degenerative Diseases group and AUidias pilot-center NEURODIN, department of Biomedicine, HEALTH, Aarhus University, Aarhus, Denmark.
Franca MarinoCenter of Research in Medical Pharmacology, University of Insubria, Varese, Italy.
Marco CosentinoCenter of Research in Medical Pharmacology, University of Insubria, Varese, Italy.
University of Insubria · ITFondazione Istituto Neurologico Nazionale Casimiro Mondino · ITAarhus University · DKUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is characterized by loss of dopaminergic neurons in substantia nigra pars compacta, α-synuclein (α-syn)-rich intraneuronal inclusions (Lewy bodies), and microglial activation. Emerging evidence suggests that CD4+ T lymphocytes contribute to neuroinflammation in PD. Since the mainstay of PD treatment is dopaminergic substitution therapy and dopamine is an established transmitter connecting nervous and immune systems, we examined CD4+ T naive and memory lymphocytes in PD patients and in healthy subjects (HS), with specific regard to dopaminergic receptor (DR) expression. In addition, the in vitro effects of α-syn were assessed on CD4+ T naive and memory cells. Results showed extensive association between DR expression in T lymphocytes and motor dysfunction, as assessed by UPDRS Part III score. In total and CD4+ T naive cells expression of D

Identifiers

PMID27652978
PMCPMC5031979
OpenAlexW2521327412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.